The transcript of the chairman’s address to the Annual General Meeting of Shareholders, for the financial year ending December 2020, is now available.
Please click to review the transcript at ASX.
Positive Results from IBI10103 Phase I Study with MagSense® HER2 Imaging Agent
December 7, 2023
Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent Imagion Biosystems Limited